Physician profile
Philip Stieg
NPI 1124047857
$2,319.03
in general payments reported to CMS, 2019-2025
11 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $243 · 2022: $968 · 2023: $30.76 · 2024: $360 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $923.56 | 2022 | |
| Integra Lifesciences Corporation | $305.58 | 2024-2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Elekta, INC. | $276.25 | 2019 | |
| Medtronic USA, INC. | $225.80 | 2020 | |
| Aesculap, INC. | $190.23 | 2024 | Progav 2.0 |
| Depuy Synthes Sales INC. | $170.01 | 2019 | |
| Cerapedics INC. | $112.61 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Carl Zeiss Meditec USA, INC. | $44.92 | 2022 | |
| Penumbra, INC. | $30.76 | 2023 | Red 72 |
| Brainlab, INC. | $22.07 | 2025 | Brainlab, INC. |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Stieg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.